Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Endometriosis 1 Colonic Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 17 Dexamethasone 15 Bortezomib 14 fludarabine phosphate 12 Melphalan 12 Lenalidomide 10 fludarabine 9 Filgrastim 8 pomalidomide 7 Tacrolimus 7 Peripheral Blood Stem Cell Transplantation 7 Rituximab 6 Radiotherapy 6 Etoposide 6 Whole-Body Irradiation 5 Cord Blood Stem Cell Transplantation 5 Calcium Dobesilate 5 Busulfan 5 Antilymphocyte Serum 5 sargramostim 4 Sirolimus 4 Panobinostat 4 Mycophenolic Acid 4 Methylprednisolone 4 Cyclosporine 4 carfilzomib 3 Vorinostat 3 Stem Cell Transplantation 3 Prednisone 3 Methotrexate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasms, Plasma Cell × Atorvastatin × Clear all

NCT00164086 2006-10-11

Atorvastatin in Myeloma

Bayside Health

Phase 1 Unknown

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡